NCT02020668Unknown2 期
Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial
Macmillan Research Group UK1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2014年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 82
- 试验地点
- 1
- 主要终点
- Pain
研究概览
简要总结
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients older than 18 years
- •History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
- •Had RA by American College of Rheumatology (ACR) criteria
- •ACR functional RA class I, II or III
- •Hemoglobin more than 8g/dL without evidence of active bleeding
- •Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
- •standard conventional medicine were allowed within the approved dosage regimen
排除标准
- •connective tissue disease
- •any other alternative or complementary medicine with in last 3 months.
- •corticosteroid, disease modifying medicines
- •Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse
结局指标
主要结局
Pain
时间窗: Change from baseline in Numerical Scale Downie at 16 weeks
次要结局
- Quality of Life(Change from Baseline in Short Form (SF) 36 at 16 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
Lovastatin for the Treatment of Mildly Active Rheumatoid ArthritisRheumatoid ArthritisNCT00302952National Institute of Allergy and Infectious Diseases (NIAID)64
已完成
不适用
BeSt, BehandelStrategieën in Reumatoïde Artritis.NL-OMON24149Dutch College of Health Insurance Companies508
已完成
3 期
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisRheumatoid ArthritisNCT05814627AbbVie487
已完成
不适用
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid ArthritisRheumatoid ArthritisNCT02288520Nordic Pharma SAS854
已完成
不适用
A Physiotherapist Led Intervention to Promote Physical Activity in Rheumatoid Arthritis - a Pilot StudyRheumatoid ArthritisNCT03644160University of Limerick58